CPHI Milan 2026: Bioprox Healthcare participated in CPHI Milan 2026

October 15, 2026

Bioprox Healthcare attended CPHI Milan, one of the leading international events for the pharmaceutical industry.

Bioprox Healthcare participated in CPHI Milan 2026, highlighting its expertise in probiotic strains and CDMO manufacturing solutions for the pharmaceutical and healthcare industries.

From October 6 to 8, 2026, Bioprox Healthcare attended CPHI Milan, one of the leading international events for the pharmaceutical industry.

With growing interest in microbiome-based solutions, the event provided an opportunity to connect with industry professionals and discuss the development of innovative probiotic and postbiotic products.

Probiotic strains for healthcare applications

Probiotics are gaining increasing attention across several healthcare fields, including women's health, digestive health and microbiome-related applications.

With a portfolio of over 3,000 microbial strains and decades of expertise in microbial fermentation, Bioprox Healthcare supports companies developing probiotic and postbiotic solutions tailored to evolving healthcare needs.

As a Contract Development and Manufacturing Organization (CDMO), we provide specialized manufacturing services covering fermentation, centrifugation, freeze-drying and formulation, supporting projects from laboratory development to industrial-scale production.

Our participation in CPHI Milan reinforced our commitment to helping pharmaceutical and healthcare companies transform innovative concepts into reliable, scalable products.

Let's develop your next project

Looking for a reliable, certified probiotic strains or a trusted CDMO partner for your next pharmaceutical or healthcare project?

Discover how Bioprox Healthcare can support your development and manufacturing needs.

Interested by our services?

Contact us